On Tuesday, a tiny shred of data on Amgen’s lead obesity candidate — not yet verified — erased $12 billion in market value.

Johnson & Johnson has sued a U.S. government agency over a closely watched dispute focusing on payment methods for some ...

The agency’s ability to hire and retain skilled employees may be in jeopardy given Trump ally Robert F. Kennedy Jr.’s ...

Biotech startup Orna Therapeutics has cut more jobs in its second round of layoffs in the last year, STAT has learned. Orna ...

The Department of Justice on Tuesday sued to prevent UnitedHealth Group from buying Amedisys, one of the largest home health ...

The U.S. syphilis epidemic slowed dramatically last year, gonorrhea cases fell and chlamydia cases remained below prepandemic ...

Narcotics Anonymous and Salvation Army are often hostile to use of the addiction medications buprenorphine and methadone.

Neurogene shares tumbled 35% last night after it disclosed that a pediatric patient with Rett syndrome experienced a severe ...

Pfizer's head of digital devices says the industry is close to a 'revolution' in using measures from wearables in clinical ...

The company behind ChatGPT didn’t set out to tackle health care. But despite ongoing concerns about its technology’s tendency ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

A surprise finding by two independent research teams and a venture capital mega-round have birthed a biotech looking to treat ...